PGC-1 is known to be induced in response to -adrenergic agonism [32]. with these data, 3-collapse overexpression of PGC-1 in undamaged myocardium of transgenic mice improved cardiac lipin 1 and ERR/ manifestation. Similarly, injection of the 2-adrenergic agonist clenbuterol induced PGC-1 and lipin 1 manifestation, and the induction in lipin 1 after clenbuterol occurred inside a PGC-1-dependent manner. In contrast, manifestation of PGC-1, ERR, ERR, and lipin 1 was down-regulated in faltering heart. Cardiac activity was also diminished, while cardiac phosphatidate content was improved, in failing heart. Collectively, these data suggest that lipin 1 is the principal lipin protein in the myocardium and is controlled in response to physiologic and pathologic stimuli that effect cardiac rate of metabolism. mice show neonatal hepatic steatosis, life-long deficiencies in adipose tissue development, insulin resistance, and improved susceptibility to developing atherosclerotic lesions [6]. Based on sequence homology, additional genes encoding lipin proteins (lipin 2 and lipin 3) were also recognized. The three lipin proteins show dissimilar patterns of tissue-specific manifestation [7]. Two unique molecular INSR functions for lipin proteins have emerged. Lipin 1 functions in the nucleus like a transcriptional coregulatory protein by interacting with DNA-bound transcription factors and recruiting additional transcriptional regulators that possess histone modifying activity [8, 9]. For example, lipin 1 interacts with the peroxisome proliferator-activated receptor (PPAR) and its coactivator protein PPAR coactivator-1 (PGC-1) and raises manifestation of genes involved in fatty acid oxidation (FAO) in liver [8]. Remarkably, lipin proteins also possess enzymatic activity like a Mg2+-dependent phosphatidic acid phosphohydrolase (PAP) enzyme [7, 10, 11]. PAP enzymes catalyze the formation of diacylglycerol from phosphatidic acid (PA); the penultimate step in triglyceride synthesis. In the myocardium, PAP activity is known to be dynamically-regulated. For example, prior GW438014A to the cloning of lipins as PAP enzymes, it was shown that myocardial PAP activity was improved in streptozotocin-induced diabetic rats, but decreased in JCR:LA corpulent rats [12, 13]. More recently, the manifestation of lipin 1 and cardiac PAP activity was found to be decreased in Zucker GW438014A diabetic fatty rats and human being subjects with type 2 diabetes mellitus [14]. We have hypothesized that lipin 1 is the cardiac-enriched lipin protein and that lipin 1 manifestation and activity is definitely controlled in the myocardium in response to physiologic and pathophysiologic GW438014A stimuli. We also wanted to test our hypothesis the PGC-1 coactivator was regulating the inducible manifestation of lipin 1 in GW438014A myocardium and targeted to identify transcription factor partners for PGC-1 with this response. In this work, we resolved these hypotheses using a variety of model systems. We found that [1] lipin 1 is the main lipin protein in the heart, [2] lack of lipin 1 in the fld mouse hearts prospects to increased build up of cardiac PA, [3] the manifestation of lipin 1 is definitely decreased in faltering heart and improved in response to -adrenergic signaling, and [4] that lipin 1 is definitely a target gene of estrogen related receptors (ERRs) and PGC-1 in cardiac myocytes through a novel intronic promoter. These studies provide fresh info concerning the rules of this pathway in myocardium. 2. Materials and methods 2.1. Mouse studies Mice constitutively deficient in lipin 1 (mice), were compared to wild-type (+/+) littermate control mice (Balb/cByJ strain). The PGC-1 knockout (PGC-1 ?/?) mice [15] were extensively backcrossed ( 10 decades) into C57BL/6J background mice and were compared to C57BL/6J wild-type (WT) settings. Cardiac-specific PGC-1 (MHC-tetON-PGC-1) [16] overexpressing double transgenic mice are purebred FVB/N and were compared to littermate mice singly transgenic for the MHC-rtTA construct. FVB/N GW438014A mice expressing extremely high levels of Cre-recombinase inside a cardiac-specific manner (TG9 mice) develop dilated cardiomyopathy and death from congestive heart failure as previously explained [17]. TG9 mice were compared to littermate non-transgenic mice to determine the effects of heart failure and lipin 1 manifestation. All studies were carried out with age-.
Categories